Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Langtian Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chongqing, China, specializing in the research, development, production, and sale of chemical raw materials and finished drug products. As a core subsidiary of the Langtian Group, the company operates modern manufacturing facilities that comply with national GMP standards, producing a wide range of medications across therapeutic areas such as cardiovascular health, anti-infectives, and respiratory diseases. The company is recognized for its integration of R&D with high-volume manufacturing, supplying both finished dosages and active pharmaceutical ingredients (APIs) to domestic and international markets. Its product portfolio includes several widely used generic medications, including treatments for hypertension and various bacterial infections. Langtian Pharmaceutical continues to expand its market presence through a commitment to quality-driven pharmaceutical production and strategic industrial scaling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 重庆朗天制药.